GlassScriptPhysician profile
Ashley Wall Crawford
NPI 1013493550
$2,556.38
in general payments reported to CMS, 2019-2025
18 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $986 · 2022: $664 · 2023: $654 · 2024: $87.07 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $619.37 | 2021-2023 | Altis, Speedicath, Isiris Astent Removal Device |
| Teleflex LLC | $347.33 | 2021-2023 | Urolift |
| Axonics, INC. | $291.76 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $280.32 | 2021-2025 | Airsupra |
| Medtronic, INC. | $203.54 | 2022-2023 | Interstim |
| Cvrx, INC. | $136.12 | 2023 | Barostim Neo System |
| Janssen Biotech, INC. | $120.53 | 2021-2023 | Erleada |
| Astellas Pharma US INC | $106.09 | 2021-2022 | |
| Novo Nordisk INC | $102.24 | 2025 | Ozempic |
| Dendreon Pharmaceuticals LLC | $95.79 | 2021-2023 | Provenge |
| Baxter Healthcare | $55.36 | 2022-2023 | |
| Urovant Sciences INC | $47.76 | 2022 | |
| Janssen Scientific Affairs, LLC | $33.87 | 2021 | |
| Pfizer INC. | $33.70 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.97 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $19.94 | 2021 | |
| Merck Sharp & Dohme LLC | $18.60 | 2021 | |
| Amgen INC. | $17.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.